BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23856904)

  • 1. Role of p62/SQSTM1 in liver physiology and pathogenesis.
    Manley S; Williams JA; Ding WX
    Exp Biol Med (Maywood); 2013 May; 238(5):525-38. PubMed ID: 23856904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SQSTM1/p62 and Hepatic Mallory-Denk Body Formation in Alcohol-Associated Liver Disease.
    Qian H; Ding WX
    Am J Pathol; 2023 Oct; 193(10):1415-1426. PubMed ID: 36906265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide stimulates p62-dependent autophagy-like aggregate clearance in hepatocytes.
    Chen C; Deng M; Sun Q; Loughran P; Billiar TR; Scott MJ
    Biomed Res Int; 2014; 2014():267350. PubMed ID: 24683544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vault-phagy: a phase-separation-mediated selective autophagy of vault, a non-membranous organelle.
    Kurusu R; Morishita H; Komatsu M
    Autophagy; 2024 Feb; 20(2):441-442. PubMed ID: 37815214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p62/SQSTM1 accumulation due to degradation inhibition and transcriptional activation plays a critical role in silica nanoparticle-induced airway inflammation via NF-κB activation.
    Wu Y; Jin Y; Sun T; Zhu P; Li J; Zhang Q; Wang X; Jiang J; Chen G; Zhao X
    J Nanobiotechnology; 2020 May; 18(1):77. PubMed ID: 32429946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function.
    Sultana MA; Cluning C; Kwong WS; Polain N; Pavlos NJ; Ratajczak T; Walsh JP; Xu J; Rea SL
    PLoS One; 2021; 16(11):e0259556. PubMed ID: 34735553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities.
    Tan CT; Soh NJH; Chang HC; Yu VC
    FEBS J; 2023 Feb; 290(4):892-912. PubMed ID: 34882306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy suppresses tumorigenesis through elimination of p62.
    Mathew R; Karp CM; Beaudoin B; Vuong N; Chen G; Chen HY; Bray K; Reddy A; Bhanot G; Gelinas C; Dipaola RS; Karantza-Wadsworth V; White E
    Cell; 2009 Jun; 137(6):1062-75. PubMed ID: 19524509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in molecular function of p62 protein and its role in diseases].
    Sui X; Xu P; Duan C; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1374-1389. PubMed ID: 37154312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death.
    Bjørkøy G; Lamark T; Brech A; Outzen H; Perander M; Overvatn A; Stenmark H; Johansen T
    J Cell Biol; 2005 Nov; 171(4):603-14. PubMed ID: 16286508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unexpected tumor suppressor role of SQSTM1/p62 in liver tumorigenesis.
    Chao X; Ni HM; Ding WX
    Autophagy; 2022 Feb; 18(2):459-461. PubMed ID: 34870542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTX80, a novel compound targeting the autophagy receptor p62/SQSTM1 for treatment of cancer.
    Kalid O; Gotliv I; Levy-Apter E; Beker DF; Cherniavsky-Lev M; Rotem E; Miron N
    Chem Biol Drug Des; 2022 Nov; 100(5):623-638. PubMed ID: 35322538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P62/SQSTM1 at the interface of aging, autophagy, and disease.
    Bitto A; Lerner CA; Nacarelli T; Crowe E; Torres C; Sell C
    Age (Dordr); 2014 Jun; 36(3):9626. PubMed ID: 24557832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates.
    Schlütermann D; Berleth N; Deitersen J; Wallot-Hieke N; Friesen O; Wu W; Stuhldreier F; Sun Y; Berning L; Friedrich A; Mendiburo MJ; Peter C; Wiek C; Hanenberg H; Stefanski A; Stühler K; Stork B
    Sci Rep; 2021 Jul; 11(1):13863. PubMed ID: 34226595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichoplein binds PCM1 and controls endothelial cell function by regulating autophagy.
    Martello A; Lauriola A; Mellis D; Parish E; Dawson JC; Imrie L; Vidmar M; Gammoh N; Mitić T; Brittan M; Mills NL; Carragher NO; D'Arca D; Caporali A
    EMBO Rep; 2020 Jul; 21(7):e48192. PubMed ID: 32337819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SQSTM1/p62 inhibition impairs pro-survival signaling in hypoxic human dendritic cells.
    Coppola F; Monaci S; Falsini A; Aldinucci C; Filippi I; Rossi D; Carraro F; Naldini A
    Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119625. PubMed ID: 37981035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sequestosome 1 protein: therapeutic vulnerabilities in ovarian cancer.
    Nurzadeh M; Ghalandarpoor-Attar SM; Ghalandarpoor-Attar SN; Rabiei M
    Clin Transl Oncol; 2023 Oct; 25(10):2783-2792. PubMed ID: 36964889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SQSTM1 facilitates oocyte maturation through inducing ACLY degradation mediated by selective autophagy.
    Schatten H
    Cell Cycle; 2023 May; 22(9):1074-1076. PubMed ID: 36786531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p62 works as a hub modulation in the ageing process.
    Fan X; Huang T; Tong Y; Fan Z; Yang Z; Yang D; Mao X; Yang M
    Ageing Res Rev; 2022 Jan; 73():101538. PubMed ID: 34890823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p62 bodies: Phase separation, NRF2 activation, and selective autophagic degradation.
    Komatsu M
    IUBMB Life; 2022 Dec; 74(12):1200-1208. PubMed ID: 36331376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.